Hospital cost effect of a heart failure disease management program: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial

American Heart Journal

Volumn 151, Issue 5, 2006, Pages 1013-1018

  Gregory, Douglas ^a   Kimmelstiel, Carey ^b   Perry, Kathleen ^a   Parikh, Amay ^b   Konstam, Varda ^c   Konstam, Marvin A ^b  

^a Cardiovascular Clinical Studies   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BUDGET; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; HEALTH PROGRAM; HEART FAILURE; HOSPITAL COST; HOSPITAL UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; RISK FACTOR; TREATMENT PLANNING;

EID: 33646099140     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.06.040     Document Type: Article

References (24)

1. Occonell J.B., and Bristow M.R. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 13 (1994) S107-S112
2. Ryden-Bergsten T., and Andersson F. The health care costs of heart failure in Sweden. J Int Med 246 (1999) 275-284
3. Galbreath A.D., Krasuski R.A., Smith B., et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 110 (2004) 1-9
4. Berry C., Murdoch D.R., and McMurray J.J.V. Economics of chronic heart failure. Eur J Heart Fail 3 (2001) 283-291
5. Kimmelstiel C., Leviner D., Perry K., et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial. Circulation 110 (2004) 1450-1455
6. McAlister F.A., Lawson F.M.E., Teo K.K., et al. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 110 (2001) 378-384
7. Manning W.G., Newhouse J.P., Duan N., et al. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev 77 (1987) 251-277
8. Neter J., Kutner M.H., Nachtsheim C.J., et al. Applied linear statistical models (1996), WCB/McGraw-Hill, Boston (Mass)
9. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 78 (1983) 605-610
10. Medicare program: proposed changes to the hospital inpatient prospective payment systems and fiscal year 2005 rates. Fed Regist 69 (2004) 28195-28818
11. Gold R.G., Siegel L.B., and Weinstein M.C. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
12. Meeker W.Q., and Escobar L.A. Statistical methods for reliability data (1998), John Wiley & Sons, Inc., New York
13. Krumholz H.M., Amatruda J., Smith G.L., et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 39 (2002) 83-89
14. Stewart S., Marley J.E., and Horowitz J.D. Effects of multidisciplinary home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure. Lancet 354 (1999) 1077-1083
15. Weinberger M., Oddone E.Z., and Henderson W.G. Does increased access to primary care reduce hospital readmissions?. N Engl J Med 334 (1996) 1441-1447
16. Galbreath D.A., Krasuski R.A., Smith B., et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 110 (2004) 1-9
17. DeBusk R.F., Miller N.H., Parker K.M., et al. Care management for low-risk patients with heart failure: a randomized controlled trial. Ann Intern Med 141 (2004) 606-613
18. Riegel B., Carlson B., Kopp Z., et al. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med 162 (2002) 705-712
19. Rich M.W., Beckham V., Wittenberg C., et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333 (1995) 1190-1195
20. Rich M.W. Heart failure disease management programs: efficacy and limitations. Am J Med 110 (2001) 410-412
21. Gregory D., Udelson J.E., and Konstam M.A. Economic impact of beta blockade in heart failure. Am J Med 110 (2001) 74S-80S
22. Australia/New Zealand Heart Failure Research Collaborative Group. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 349 (1997) 375-380
23. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial. Lancet 353 (1999) 9-13
24. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302